TSX-V:RKV - TSX Venture Exchange - CA75103L1013 - Common Stock - Currency: CAD
TSX-V:RKV (3/7/2025, 7:00:00 PM)
0.15
+0.01 (+7.14%)
The current stock price of RKV.CA is 0.15 CAD. In the past month the price decreased by -21.05%. In the past year, price increased by 100%.
Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2020-02-07. The firm is focused on the development of new cancer treatments based on novel deoxyribonucleic acid (DNA)-damage response technologies. Its drug development pipeline includes kt-2000AI and kt-3000 series. The company is engaged in employing the proprietary Deep Docking AI Platform to rapidly screen billions of potential drug candidates against PARP (kt-2000AI) and other novel DDR targets to generate drug candidates that can be advanced to human trials or developed in collaboration with pharmaceutical partners. Its kt-3000 series represents a novel class of bi-functional small-molecule drug candidates that has been designed to combine inhibition of both poly (ADP)-ribose polymerase (PARP) and histone deacetylase (HDAC) in a single molecule. This novel approach has the potential to overcome treatment resistance and provide clinical benefit to cancer patients.
RAKOVINA THERAPEUTICS INC
105 - 1008 Beach Avenue
Vancouver BRITISH COLUMBIA V6B 0A5 CA
Employees: 0
Company Website: https://www.rakovinatherapeutics.com/
Investor Relations: https://www.rakovinatherapeutics.com/corporate-profile/
Phone: 16046190225
The current stock price of RKV.CA is 0.15 CAD. The price increased by 7.14% in the last trading session.
The exchange symbol of RAKOVINA THERAPEUTICS INC is RKV and it is listed on the TSX Venture Exchange exchange.
RKV.CA stock is listed on the TSX Venture Exchange exchange.
RAKOVINA THERAPEUTICS INC (RKV.CA) has a market capitalization of 21.12M CAD. This makes RKV.CA a Nano Cap stock.
RAKOVINA THERAPEUTICS INC (RKV.CA) currently has 0 employees.
RAKOVINA THERAPEUTICS INC (RKV.CA) has a support level at 0.14 and a resistance level at 0.16. Check the full technical report for a detailed analysis of RKV.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RKV.CA does not pay a dividend.
RAKOVINA THERAPEUTICS INC (RKV.CA) will report earnings on 2025-04-25.
RAKOVINA THERAPEUTICS INC (RKV.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).
ChartMill assigns a technical rating of 5 / 10 to RKV.CA. When comparing the yearly performance of all stocks, RKV.CA is one of the better performing stocks in the market, outperforming 94.87% of all stocks.
Over the last trailing twelve months RKV.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS decreased by -20.6% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -62.38% | ||
ROE | -107.71% | ||
Debt/Equity | 0.45 |